Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
Manufacture and commercialization of high quality recycled polyolefin films using an innovative continuous extrusion recycling process assisted by sc-CO2 for printed plastic waste (CLIPP PLUS)

Framework: Horizon 2020 — Societal Challenges
Programme: Climate action, environment,  resource efficiency and raw materials
Action type: SME instrument
Countries involved: United Kingdom
Call: Boosting the potential of small businesses for eco-innovation and a sustainable supply of raw materials (H2020-SMEINST-2-2014, 2014)
Start date: 2015-07-01
End date: 2017-12-31
Duration (months): 30.0
Total project cost (EUR): 760987.5
EU funding (EUR): 532691.25
Participants: 1
Project status: CLOSED

Every year at EU level more than 240 kt of waste printed or laminated films are generated by converting industry. Mechanical recycling of this waste is challenging due to the presence of inks and adhesives so that this recycled material is only suitable for manufacture low value products (rubbish bags, irrigation pipes and pots) when not diverted to energy recovery and landfill which has a negative environmental and societal impact. CLIPP + aims to introduce into the market a cost-competitive environmentally friendly recycled PE film to be reused in the original or other high added value applications (such as packaging films) through a innovative technology based on a previous EU project (CLIPP) which demonstrated the effectiveness of supercritical CO2 technology to remove the contaminants associated to this type of printed/laminated plastic packaging. Turning waste into a valuable resource is a goal for SKYMARK in order to contribute to raw material savings and more sustainable development. CLIPP+ project is fully aligned with Directives 94/62/EC and 2008/98/EC encouraging the reuse of materials obtained from recycled packaging waste for the manufacturing of packages improving market conditions and reaching zero plastic waste to landfill by 2020 in Europe. SKYMARK (UK) is one of the leading independent manufacturers of flexible packaging solutions in Europe. The company has an excellent reputaton in the converting industry for the quality fo its products for packaging sector including films for fresh produce, flowers, labels, stationery, textile, tissue, food & drink, wipes, hygiene & medical and other industrial & technical goods. SKYMARK emphasis is on developing innovative, technologically advanced and environmental aware products. SKYMARK cares for the environment and offers a range of sustainable packaging solutions. SKYMARK is an accredited re-processor of plastic waste materials by UK Department for Environment, Food & Rural Affairs (DEFRA) for t

Keywords: super critic co2 cleaning agent post industrial printed or laminated film waste,environmentally friendly flexible packaging solutiont,tissue,wipes,hygiene packaging sectors
Reconfigurable silicon architecture for connected intelligent lighting. (SmartComm-LED)

Framework: Horizon 2020 — Societal Challenges
Programme: Secure, clean and efficient energy
Action type: SME instrument
Countries involved: Ireland
Call: Stimulating the innovation potential of SMEs for a low carbon energy system (H2020-SMEINST-1-2014, 2014)
Start date: 2015-05-01
End date: 2015-09-30
Duration (months): 5.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

Lighting accounts for 19% of energy consumption in the developed world. However low energy lighting technologies are rapidly replacing the traditional incandescent technology and by far the most rapidly growing low energy lighting technology today is LED. The LED lighting market was worth $16.5B in 2013, is growing at a CAGR in excess of 16% and is projected to continue growing at this rate through to 2018 when the market is projected to be worth $33.5B. Not only is lighting moving towards more energy efficient technologies such as LED, but the way in which lighting is used is also undergoing a dramatic evolution. Lighting is becoming increasingly “connected” and increasingly “intelligent” and it is this growing market that Ikon Semiconductor aims to address with this proposal. The target customers for the outcome of this project are manufacturers of LED lighting power supply systems. The project aims to develop an optimum re-configurable silicon architecture for “connected intelligent lighting” systems for use in smart buildings including residential, commercial and industrial. It will enable a single highly configurable chip-set solution with an optimum hardware/software co-design to operate with any wireless or wired communications protocol and will allow the developers of advanced lighting power supply systems to re-configure their design to address a broad range of applications. This will replace the currently available disparate range of fixed-function solutions and will enable reduced cost and time-to-market for our target customers. Such a solution has global commercial potential. In this Phase-1 SME instrument feasibility study we aim to use both new and existing end-user advisor relationships to carry out a market validation and an economic viability analysis. It is also our intention to submit a business plan for a Phase 2 SME Instrument during 2015.

Keywords: led lighting,intelligent lighting,connected lighting,semiconductor
External Automatic Glaucoma Laser (EAGLE) for the first-line glaucoma treatment: Commercial prototype development and validation (GLAUrious)

Framework: Horizon 2020 — Societal Challenges
Action type: Innovation actions
Countries involved: Italy,Germany,Israel,Belgium,United Kingdom
Call: Fast Track to Innovation Pilot (H2020-FTIPilot-2015-1, 2015)
Start date: 2016-09-01
End date: 2020-02-29
Duration (months): 42.0
Total project cost (EUR): 4036138.25
EU funding (EUR): 2480275.0
Participants: 5
Project status: CLOSED

The GLAUrious project is promoting the novel External Automatic Glaucoma Laser (EAGLE) device with the goal of providing accessible first-line treatment for glaucoma. Glaucoma, a chronic disease causing progressive optic nerve degeneration, is the leading cause of irreversible blindness globally. Although incurable, disease progression is delayed by reducing intraocular pressure, thus preventing blindness. Some 64 million people worldwide suffer from glaucoma. Current first-line treatment requires daily eye drops, a strict regimen causing 50% patient dropout after 1 year. Laser treatment for glaucoma has been in use for many years. Its effect lasts for 2−5 years and is repeatable. This traditional 10-minute procedure, involving contact with the patient’s eye, requires the expertise of glaucoma specialists. Consequently, costs are high and accessibility to the general population is low. The novel EAGLE procedure is automated, non-invasive, non-contact, painless and user friendly—1 second of treatment by one press of a button. This revolutionary cost-effective device could be safely used by the world’s 212,000 ophthalmologists, thus becoming a primary treatment for glaucoma, overcoming serious problems of eye drop non-compliance and effectively preventing disease deterioration. GLAUrious project aims to ease commercialization of the EAGLE device by securing clinical prototype validation, streamlining commercial production, optimizing component costs, disseminating to key opinion leaders and distributors, and refining commercial strategy. Validation of EAGLE will allow its commercialization enabling penetration of the ophthalmic market and boosting of the industrial consortium partners (BEL and MCI). The multidisciplinary GLAUrious Consortium, with its four partners from three member states (Belgium, Italy, UK) and one associated state (Israel), incorporates two SMEs and two academic hospitals.

Keywords: glaucoma,laser trabeculoplasty,medical device
Collaborative Recommendations and Adaptive Control for Personalised Energy Saving (enCOMPASS)

Framework: Horizon 2020 — Societal Challenges
Programme: Secure, clean and efficient energy
Theme: Reducing energy consumption and carbon foorpint by smart and sustainable use
Action type: Innovation actions
Countries involved: Germany,Italy,Germany,Switzerland,Lithuania,Greece,Greece,Greece,Hungary,Romania
Call: Behavioural change toward energy efficiency through ICT (H2020-EE-2016-RIA-IA, 2016)
Start date: 2016-11-01
End date: 2019-11-30
Duration (months): 37.0
Total project cost (EUR): 3312589.29
EU funding (EUR): 2000350.0
Participants: 16
Project status: CLOSED

Achieving the European environmental objectives for 2020 requires not only technological progress, but also a major change in energy consumption behaviour. The enCOMPASS project will implement and validate an integrated socio-technical approach to behavioural change for energy saving, by developing innovative user-friendly digital tools to make energy consumption data available and understandable for different stakeholders (residents, visitors, public actors, building managers, utilities and ICT-providers) in ways that empower them to achieve energy savings and manage their needs in energy efficient, cost-effective and comfortable ways. It will demonstrate how this can be achieved with a holistic approach that integrates visualisation of energy data collected from smart sensors, user-generated information and context-aware collaborative recommendations for energy saving, intelligent control and adaptive gamified incentives. The enCOMPASS system will be realized as an open platform combining 1) context-dependent energy usage information from in-home sensors (smart meters and smart home appliances for heat and electricity), 2) user-generated information (automatic and manual activity tracking), 3) adaptive gamified energy visualisation and 4) intelligent controls and automation. The platform is developed to achieve sustainable changes in user energy consumption patterns without compromising comfort levels. The enCOMPASS system will integrate existing technology, product and service offerings of the utility and technology partners, customize and extend them to offer improved and new types of their offerings. The enCOMPASS platform is the heart of a new business ecosystem that enables players in the energy domain to develop their own white-label solutions on top of the platform, or to integrate and use individual services or platform modules. This set-up results in societal, environmental and economic impact of enCOMPASS above and beyond the reach of the pilots.

Keywords: environmental sustainability,serious and persuasive games,application gamification,smart grids,smart meters,community sensing,behavior change
Translational control in infection biology: riboproteogenomics of bacterial pathogens (PROPHECY)

Framework: Horizon 2020 — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Starting grants
Action type: ERC actions
Panel: Integrative Biology: from Genes and Genomes to Systems
Panel description: Genetics, epigenetics, genomics and other ‘omics studies, bioinformatics, systems biology, genetic diseases, gene editing, innovative methods and modelling, ‘omics for personalised medicine
Countries involved: Belgium
Call: ERC Starting Grant (ERC-2018-STG, 2018)
Start date: 2018-11-01
End date: 2023-10-31
Duration (months): 60.0
Total project cost (EUR): 1498625.0
EU funding (EUR): 1498625.0
Participants: 1
Project status: SIGNED

My recent findings revealed translation of numerous previously unidentified (small) open reading frames and expression of alternative N-terminal proteoforms when studying bacterial translation. This proposal aims at unraveling the repertoire of bacterial pathogen proteoforms employed to establish a successful infection in a mammalian host cell. While deep sequencing has enabled the study of gene expression at the transcript level in both pathogen and host simultaneously, the depth of sequencing has so far proven to be unsatisfactory. Moreover, the study of bacterial proteome changes upon infection remains highly unexplored because of the higher proteome complexity of the host cell compared to the pathogen. These challenges clearly stresses the need for novel strategies based on complementary proteogenomics approaches enabling translation control studies in bacterial pathogens in a host context . I here propose the development and application of a complementary cutting-edge proteogenomic toolset which will enable for the first time targeted systematic genome- and proteome-wide surveys of bacterial transcriptional and translational activity during actual host cell infection. This ambitious endeavor will lead to: I) Establishment of dual Ribo-seq that allows the selective isolation of host or bacterial ribosomes, enabling to study the bacterial translatome in a host cell context. II) Development of tailored proteomics strategies permitting the selective isolation of (nascent) bacterial protein N-termini and enrichment of bacterial small ORF-encoded polypeptides (SEPs). Further, proteome-wide subcellular localization and protein stability studies will provide a dynamic view on bacterial protein expression. II) Bacterial proteoform interaction maps by the development of an innovative proxeome strategy. The identification of new pathogen virulence factors will contribute to the development of therapeutics and diagnostics for multiple models of infectious diseases.

Keywords: proteogenomics,gene annotation,small open reading frames,proteoforms
Industrial manufacturing of conductive, transparent and flexible electrodes with nanoinks for organic electronic devices such as OPV and OLED lighting (CLEARSILVER)

Framework: Horizon 2020 — Industrial Leadership
Programme: Nanotechnologies, Advanced Materials, Advanced Manufacturing and Processing, and Biotechnology
Theme: Nanotechnologies
Action type: SME instrument
Countries involved: France,France
Call: Accelerating the uptake of nanotechnologies advanced materials or advanced manufacturing and processing technologies by SMEs (H2020-SMEINST-2-2016-2017, 2016)
Start date: 2016-09-01
End date: 2019-02-28
Duration (months): 30.0
Total project cost (EUR): 3035278.75
EU funding (EUR): 2124695.13
Participants: 2
Project status: CLOSED

This project was already submitted and has received the Seal of Excellence certificate delivered by the EU Commission. This new version is reviewed and amended based on the evaluation summary report. Nowadays, Indium Tin Oxide (ITO) is the main material used for transparent conductive films (TCF). These films have significant drawbacks such as fragility, indium depletion and high manufacturing cost. A promising alternative is a conductive patterned grid based on silver nanoparticles covered with a protective and conductivity enhancing zinc oxide nano-layer. To accelerate the uptake of this processing technology, the printed electronics market needs a complete solution of industrial inks and inkjet printing at large scale and high speed. This is the objective of the CLEARSILVER solution proposed by KELENN Technology (KT) - manufacturer of industrial solutions for inkjet printing - and Genes’Ink (GNK) - leader on the conductive and semi-conductive nanoinks market. The CLEARSILVER project is led by GNK in collaboration with KT. This partnership benefits from their core technical and business expertise. Since beginning 2014, GNK and KT have successfuly developed a complete pilot solution including nanomaterials kilo-scale manufacturing and an online demonstrator printer, KSCAN-PE400 presented at LOPEC 2016. The SME Instrument funding will support our objective to bring to the market a sustainable industrial solution for TCF manufacturing. The targeted market is the flexible TCF for OPV, OLED lighting and later on OLED displays. Driven by innovative applications, the business forecast for these two segments show an exponential growth in the next five years (+ 75 % CAGR). The OPV and OLED lighting market will reach a total size of $US 176 million in 2020. OPV and OLED lighting manufacturers will be the first to take advantage of our solution. Conventional EU industries like the printing sector will also benefit from it with new printed electronics opportunities.

Keywords: nanomaterials,nanoinks,inkjet,transparent conductive films,flexible electronics,industrial scale,high throughput,olae,oled lighting,zinc oxide zno,silver ag
Industrial Cell Factories and Sustainable Bioprocessing for Future Bioeconomy (CelESTial)

Framework: Horizon 2020 — Spreading excellence and widening participation
Programme: Widening participation and spreading excellence
Theme: Improved access to Excellence
Action type: Coordination and support actions
Countries involved: Estonia,Denmark
Call: Teaming Phase 1 (H2020-WIDESPREAD-04-2017-TeamingPhase1, 2017)
Start date: 2017-09-01
End date: 2018-08-31
Duration (months): 12.0
Total project cost (EUR): 397325.0
EU funding (EUR): 397325.0
Participants: 2
Project status: CLOSED

Biosustainablility is an important goal for humanity as it addresses many global challenges we face. The rapidly emerging field of synthetic biology provides a powerful opportunity to make this goal a reality. By combining molecular biology and engineering, synthetic biology represents a paradigm shift where biology is becoming an engineering discipline with tools to design and construct cells and organisms with novel functions. These can be used as cell factories to replace and extend current chemical and pharmaceutical production techniques in an environmentally sustainable way. A number of cell factories developed in recent years have replaced existing production techniques because they are economically superior, but may be utilized in coming years to address global climate change. To foster the development of synthetic biology and cell factory development, we propose a Teaming partnership between the Estonian Centre for Synthetic Biology (Estonia) at the University of Tartu and the Novo Nordisk Foundation Center for Biosustainability (Denmark) at the Technical University of Denmark. We will create a research and development platform for the sustainable bio-manufacturing of high value chemicals and pharmaceuticals using cell factories. The platform, which relies on the concerted action of both centres, and their industrial partners, will accelerate the transition from proof-of-concept science to commercial production via a system of iterative cycles. This platform will move cell factory technology from the lab to pilot-scale production in bioreactors with less cost and development time compared with current state-of-the-art techniques. This project also aims to enhance regional development by extending the innovative biosustainable research and industrial practices of the Medicon Valley area of Denmark and Southern Sweden into the greater Nordic and Baltic Sea region.

Keywords: synthetic biology,sustainable bioprocessing,cell factories
From Local Elements to Globally Ordered TOPological states of matter (LEGOTOP)

Framework: Horizon 2020 — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Advanced grants
Action type: ERC actions
Panel: Condensed matter physics
Panel description: Structure, electronic properties, fluids, nanosciences, biological physics
Countries involved: Israel
Call: ERC Advanced Grant (ERC-2017-ADG, 2017)
Start date: 2018-10-01
End date: 2024-09-30
Duration (months): 72.0
Total project cost (EUR): 1532163.0
EU funding (EUR): 1532163.0
Participants: 1
Project status: SIGNED

We present a novel constructive approach for realizations of topological states of matter. Our approach starts with well-understood building blocks, and proceeds towards coupling them to create the desired states. This approach promises both a guide for a tunable experimental realization of states which have not been observed so far, and a theoretical tool for deeper understanding of different topological states, their dualities and inter-relations. We will apply the constructive approach in two different directions. In the first direction our goal will be the construction of topological superconductors. Our tool will be Josephson junctions in which superconductors are coupled by two- and three-dimensional electronic non-superconducting systems. Two dimensional examples include transition metal dichalcogenides, Quantum Hall states, Quantum Anomalous Hall states, and the (111) bi-layer state, which may be viewed as a fractionalized electron-hole condensate. Three dimensional examples include Weyl semi-metals and weak topological insulators. In the second direction our goal is the construction of fractionalized spin liquid states. Our building block will be a Majorana-Cooper box, which is a superconducting quantum dot coupled to semi-conducting wires that host Majorana zero modes. We will consider arrays of such boxes. The ratio of the box's charging energy to inter-box tunnel-coupling determines whether the array is superconducting or insulating. We will aim to use insulating arrays for realizing fractionalized and non-abelian spin liquids, study the transition to the superconducting state, and search for possible relations between the topological properties on both sides of the transition. A deeper comprehension and a feasible path for realization of these states would have a profound effect on the field of topological matter and will open novel avenues for universal topological quantum computers.

Keywords: topological superconductivity,fractionalized states of matter,non abelian statistics,topological quantum computation majorana fermion
Strain-stiffening vascular graft with outstanding compliance (VASCUGRAFT)

Framework: Horizon 2020 — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Proof of concept grants
Action type: ERC actions
Panel: Condensed matter physics
Panel description: Structure, electronic properties, fluids, nanosciences, biological physics
Countries involved: Germany,Germany
Call: ERC Proof of Concept Grant (ERC-2019-PoC, 2019)
Start date: 2020-10-01
End date: 2022-09-30
Duration (months): 24.0
Total project cost (EUR): 150000.0
EU funding (EUR): 150000.0
Participants: 2
Project status: CLOSED

Cardiovascular diseases are one of the major causes of death in the EU and appropriate treatment remains challenging and expensive. Often, the only treatment option is the replacement of a native blood vessel, for example if a coronary artery bypass is needed. Although patient-derived vascular grafts remain the gold standard as a replacement of the original vessel, alternatives have to be found, as donor material is limited. Currently available synthetic grafts have several drawbacks in comparison to native blood vessels. The major drawback is the mismatch between the mechanical properties of the native vessel and the synthetic graft, thus causing major complications like intima hyperplasia. While the stress-strain-curve in synthetic grafts is linear and the grafts are relatively stiff, native blood vessels are soft and have a non-linear, strain-stiffening mechanical behavior. In our ERC Starting Grant CELLINSPIRED we have developed a material structure that allows us to mimic the strain-stiffening of blood vessels. We will employ our strain-stiffening materials in synthetic vascular grafts with broad applicability in the field of vascular surgery. Within the proposed project VASCUGRAFT we will fabricate demonstrators of such biomimetic vascular grafts and strive to find a company that licenses our invention and brings it on the national and international market.

Keywords: vascular graft,implant,soft material,mechanical compliance